Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Shinohara, Tsutomu ^a   Shiota, Naoki ^b   Kume, Motohiko ^b   Hamada, Norihiko ^b   Naruse, Keishi ^c   Ogushi, Fumitaka ^a  

^a National Hospital Organization   (Japan)

^b KOCHI UNIVERSITY   (Japan)

^c National Hospital Organization Kochi National Hospital   (Japan)

Author keywords

Fluorodeoxyglucose; Positron emission tomography; Primary tuberculous pleurisy

Indexed keywords

ETHAMBUTOL; FLUORODEOXYGLUCOSE F 18; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; GRANULOMATOUS INFLAMMATION; HEMATOTHORAX; HUMAN; HUMAN TISSUE; MALE; MALIGNANT MESOTHELIOMA; NEEDLE BIOPSY; PHYSICAL EXAMINATION; PLEURA EFFUSION; SKIN TEST; THORAX RADIOGRAPHY; TRANSTHORACIC BIOPSY; TUBERCULOUS PLEURISY;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MESOTHELIOMA; PLEURA; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; THORACOSCOPY; TUBERCULOSIS, PLEURAL;

EID: 84872142147     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-12     Document Type: Article

References (20)

1. Strauss LG. Positron emission tomography: current role for diagnosis and therapy monitoring in oncology. Oncologist 1997, 2:381-388.
2. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001, 285:914-924. 10.1001/jama.285.7.914, 11180735.
3. Zheng Z, Pan Y, Guo F, Wei H, Wu S, Pan T, Li J. Multimodality FDG PET/CT appearance of pulmonary tuberculoma mimicking lung cancer and pathologic correlation in a tuberculosis-endemic country. South Med J 2011, 104:440-445. 10.1097/SMJ.0b013e318218700a, 21886034.
4. Soussan M, Brillet PY, Mekinian A, Khafagy A, Nicolas P, Vessieres A, Brauner M. Patterns of pulmonary tuberculosis on FDG-PET/CT. Eur J Radiol 2012, 81:2872-2876. 10.1016/j.ejrad.2011.09.002, 21945403.
5. Treglia G, Taralli S, Calcagni ML, Maggi F, Giordano A, Bonomo L. Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review. J Comput Assist Tomogr 2011, 35:387-393. 10.1097/RCT.0b013e318219f810, 21586936.
6. Ichiya Y, Kuwabara Y, Sasaki M, Yoshida T, Akashi Y, Murayama S, Nakamura K, Fukumura T, Masuda K. FDG-PET in infectious lesions: The detection and assessment of lesion activity. Ann Nucl Med 1996, 10:185-191. 10.1007/BF03165391, 8800447.
7. Castaigne C, Tondeur M, de Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun 2009, 30:41-47. 10.1097/MNM.0b013e328310b38d, 19306513.
8. Park IN, Ryu JS, Shim TS. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med 2008, 33:1-3. 10.1097/RLU.0b013e31815c5128, 18097246.
9. Martinez V, Castilla-Lievre MA, Guillet-Caruba C, Grenier G, Fior R, Desarnaud S, Doucet-Populaire F, Boué F. 18F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis 2012, 16:1180-1185. 10.5588/ijtld.12.0010, 22794271.
10. Go SW, Lee HY, Lim CH, Jee WH, Wang YP, Yoo IR, Kang JY. Atypical disseminated skeletal tuberculosis mimicking metastasis on PET-CT and MRI. Intern Med 2012, 51:2961-2965. 10.2169/internalmedicine.51.8347, 23064577.
11. Via LE, Schimel D, Weiner DM, Dartois V, Dayao E, Cai Y, Yoon YS, Dreher MR, Kastenmayer RJ, Laymon CM, Carny JE, Flynn JL, Herscovitch P, Barry CE. Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [18F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. Antimicrob Agents Chemother 2012, 56:4391-4402. 10.1128/AAC.00531-12, 3421588, 22687508.
12. Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rea TH, Modlin RL. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989, 142:1114-1119.
13. Levine H, Szanto PB, Cugell DW. Tuberculous pleurisy. An acute illness. Arch Intern Med 1968, 122:329-332. 10.1001/archinte.1968.00300090039009, 5676418.
14. Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T, Bartsch P, Bury TJ. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 2004, 125:489-493. 10.1378/chest.125.2.489, 14769729.
15. Kramer H, Pieterman RM, Slebos DJ, Timens W, Vaalburg W, Koëter GH, Groen HJ. PET for the evaluation of pleural thickening observed on CT. J Nucl Med 2004, 45:995-998.
16. Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007, 131:880-889. 10.1378/chest.06-2063, 17356108.
17. Ferrer Sancho J. Pleural tuberculosis: incidence, pathogenesis, diagnosis, and treatment. Curr Opin Pulm Med 1996, 2:327-334.
18. Caramori G, Lasagna L, Casalini AG, Adcock IM, Casolari P, Contoli M, Tafuro F, Padovani A, Chung KF, Barnes PJ, Papi A, Rindi G, Bertorelli G. Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisy. PLoS One 2011, 6:e22637. 10.1371/journal.pone.0022637, 3145659, 21829471.
19. Patiala J. Initial tuberculous pleuritis in the Finnish armed forces in 1939-1945 with special reference to eventual postpleuritic tuberculosis. Acta Tuberc Scand 1954, 36(Suppl):1-57.
20. Roper WH, Waring JJ. Primary serofibrinous pleural effusion in military personnel. Am Rev Tuberc 1955, 71:616-634.